Bio Green Med Solution Inc.'s next confirmed earnings release is scheduled for November 18, 2026.
| Earnings Date | 11/18/2026 |
As of June 30, 2026, Bio Green Med Solution Inc. maintains a current ratio of 8.63, meaning it holds 8.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 8.63 |
| Quick Ratio | 7.03 |
Over the twelve months ended June 30, 2026, Bio Green Med Solution Inc. posted a negative return on equity (ROE) of -42.31, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -35.92, reflecting losses generated across the asset base. The company generates approximately 155,083.33 in revenue per employee across its workforce of 12.00, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -42.31 |
| Return on Assets (ROA) | -35.92 |
| Revenue Per Employee | 155,083.33 |
| Employee Count | 12.00 |
Over the twelve months ended June 30, 2026, Bio Green Med Solution Inc. recorded 44,000.00 in income tax expense. The company reported a pretax loss of -2.16M and -2.20M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 44,000.00 |
As of the close on October 21, 2026, Bio Green Med Solution Inc.'s stock has declined approximately 47.37% over the past 52 weeks.
| 52-Week Price Change | -47.37% |
| 50-Day Moving Average | 1.79 |
These figures cover the twelve months ended June 30, 2026. EBITDA reached -2.73M, while operating income came in at -2.74M.
| Revenue | 1.86M |
| Gross Profit | 360,000.00 |
| Operating Income | -2.74M |
| Pretax Income | -2.16M |
| Net Income | -2.20M |
| EBITDA | -2.73M |
| EBIT | -2.74M |
As of June 30, 2026, Bio Green Med Solution Inc. holds 3.79M in cash and equivalents against - - in total debt, resulting in a net debt position of -3.79M. Total book value stands at 7.16M, with working capital of 5.28M providing operational flexibility.
| Cash & Cash Equivalents | 3.79M |
| Net Debt | -3.79M |
| Equity (Book Value) | 7.16M |
| Working Capital | 5.28M |
Bio Green Med Solution Inc. produced -1.10M in operating cash flow over the twelve months ended June 30, 2026.
| Operating Cash Flow | -1.10M |
| Capital Expenditures | -1,000.00 |
| Free Cash Flow | -1.10M |
Over the twelve months ended June 30, 2026, Bio Green Med Solution Inc. posted a gross margin of 19.34, reflecting its pricing power and cost economics. The operating margin of -147.13 and net profit margin of -118.27 provide insight into operational efficiency.
| Gross Margin | 19.34 |
| Operating Margin | -147.13 |
| Pretax Margin | -115.91 |
| Profit Margin | -118.27 |
| EBITDA Margin | -146.86 |
These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 0.88 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.
| Payout Ratio | 0.88 |
Already premium?